HMGB1 and non-small cell lung carcinoma: In doing so, we found notable results in support of HMGB1 as a predictive and prognostic marker, thereby demonstrating the potential of HMGB1 as a promising target for further investigations in prospective studies, both as a single biomarker or as part of a multimarker panel for diagnostic and prognostic improvements in NSCLC.